Inspection Record

Hain-Celestial Canada, ULC — Health Canada Inspection Findings

Health CanadaInspected 2021-10-26 3 findingsStability and storageTraining and personnelOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Stability and storage

The design of the drug stability study was inadequate and/or not justified with a documented rationale.

2Training and personnel

The ongoing training of personnel was inadequate.

3Other quality system

The handling of standard operating procedures for good manufacturing practices was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2021-10-26. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Hain-Celestial Canada, ULC company profile — full history Health Canada documents, 2021 Go to Findings search